Total Funding
22
52
Total FundingNon-equity Assistance raised
Growth Score 22 in past quarter
-1 pts
Heat Score 52 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
86050
We are exosomes! We can extract any species of pure, viable, in-tact exosome from any biofluid source into pure solution.
- Mei He: Chief Science Officer
- Thomas Krol: Chief Development OfficerPast Role: Kansas Bioscience Authority, Managing Director
About the Company
Clara Biotech is a platform technology that allow for the isolation of specific cellular markers (exosomes) from very small fluid samples enabling liquid biopsy for the very early detection of cancer, Alzheimer's Disease and many others. These same markers can also be turned into a precision medicine drug delivery platform delivering targeted
drugs directly to the cells being targeted. The current gold standard is a 12 hours ultra-centrifugation process. Ours is the only platform that can take any biofluid source, and extract any species of pure viable exosome into pure solution. We are the bridge that moves research to patient.
Exosomes are one of the next major breakthroughs in Biotech. We are Clara. We are exosomes.
Women Founded